Clinical trials demonstrated that some patients using tirzepatide achieved: Major reductions in body weight Improved blood sugar control Reduced appetite and cravings Many obesity specialists consider Mounjaro one of the most effective currently available injectable medications for weight loss
No dose adjustment is needed for any degree of renal impairment, according to the Kidney Disease: Improving Global Outcomes (KDIGO) and the FDA label 12
Arch Oral Biol 60(5):776781
The best predictor for who will go on to have more serious liver disease is the amount of scar tissue, says Saab
The best non-diabetic body-composition anchor favors tirzepatide, about 75:25 fat-to-lean loss in its DXA data versus about 62:38 in semaglutides. This is cross-trial evidence, not a head-to-head maintenance-dose DXA result
Various types of supplements are also available depending on your preferences, including oral capsules, nasal sprays, and liquid drops